Mirvetuximab: Practice Changing for Some Ovarian Cancers ...Middle East

Medscape - News
Response rates were superior to those seen with other single agents in patients with platinum-resistant disease and tumors positive for folate receptor alpha. Medscape Medical News

Hence then, the article about mirvetuximab practice changing for some ovarian cancers was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mirvetuximab: Practice Changing for Some Ovarian Cancers )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News